reimbursement — Lanton Law Blog

Lanton Law Speaks With Pharmacy Times About Provider Status

Below is the description from Pharmacy Times about our discussion with them on pharmacy provider status. You can listen to the interview here.

CMS, healthcare, pharmaceuticals, pharmacyRon LantonOctober 6, 2023pharmacy, pharmacy provider status, collaborative agreement, reimbursement, New England, Massachusetts, Michigan

Vermont Enacts New PBM Law

Vermont Gov. Phil Scott (R) signed H. 353, a bill that several issues including patient steering, reimbursement transparency, spread pricing, and other PBM practices.

healthcare, pharmaceuticals, pharmacy, pharmacy benefit managerRon LantonMay 31, 2022PBM, Vermont, H. 353, spread pricing, reimbursement, pharmacy

Lanton Law Speaks with Pharmacy Times about U.S. Supreme Court Case Rutledge v. PCMA & Its Implication on Pharmacy Policy

Lanton Law was interviewed by Pharmacy Times on the implications of the October 6, 2020 U.S. Supreme Court case of Rutledge v. PCMA.

healthcare, government affairs, Medicare Part D, pharmaceuticals, pharmacy, pharmacy benefit manager, prescription drug costs, reimbursement, U.S. Supreme CourtRon LantonJuly 27, 2020Rutledge v. PCMA, U.S. Supreme Court, Kentucky Pharmacy Law, Georgia Pharmacy Law, PBM, Pharmacy Benefit Manager, reimbursement

Private Equity Presence Grows in Physician Practices As Well As Congressional Scrutiny

As the consolidation of independent physician practices continues, one finds that there is a new player in the corporatization of medicine. While hospitals, health systems and insurers continue to make physician practice acquisitions, these entities suddenly find themselves competing against private equity firms.

Congress, pharmaceuticals, Medicare, healthcare, physician, Ways and Means Committee, hospitals, insuranceRon LantonFebruary 16, 2020private equity, private equity firms, dermatology, oncology, orthopedics, urology, gastroenterology, physician, reimbursement